Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Inorganic phosphate ion homeostasis refers to the tightly regulated physiological processes that maintain stable concentrations of inorganic phosphate (Pi) in the body. This balance is essential for numerous biological functions, including bone mineralization, energy metabolism (as a component of ATP), cell signaling, and nucleic acid synthesis. Key mechanisms include intestinal absorption, renal reabsorption, hormonal regulation by FGF23, PTH, and vitamin D, and cellular sensing of Pi levels. Disruption of this homeostasis can lead to hypophosphatemia or hyperphosphatemia, commonly seen in chronic kidney disease.
Phosphate binders: Bind to phosphate in the gut, preventing absorption. Vitamin D analogs: Increase intestinal phosphate absorption. FGF23 antibodies: Increase renal phosphate reabsorption and active vitamin D levels. Cinacalcet: Lowers PTH, which indirectly affects phosphate handling by the kidneys.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inorganic Phosphate Ion Homeostasis (None).